Tag: Biotech

TechSauce

The AI Game: If Thailand Doesn’t Start Now, We Could Fall 10 Years Behind the World

On December 4, 2025, at the GLOBAL ARTIFICIAL INTELLIGENCE MACHINES AND ELECTRONICS EXPO (AIE) 2025 in Macau, Oranuch Lertsuwanakit—CEO and Co-Founder of Techsauce—joined a panel discussion titled […]
December 15th, 2025
EU-Startups

Swedish BioTech company Melt&Marble secures €7 millon to scale designer fats in beauty and food

Melt&Marble, the Swedish BioTech scale-up using precision fermentation to produce designer fats, has just raised €7.3 million in Series A funding, to scale production and bring […]
December 8th, 2025
Korea Tech Desk

Korea’s First GLP-1 Obesity Drug Fast-Tracked: Hanmi’s “Efpeglenatide” Signals Acceleration in Biotech Commercialization

A new decisive phase is coming to South Korea’s biotech sector. Hanmi Pharmaceutical’s Efpeglenatide, the nation’s first homegrown GLP-1 obesity drug, has been granted fast-track review […]
December 7th, 2025
EU-Startups

As cancer cases surge toward 35 million by 2050, Finland’s Gosta Labs raises €7.5 million to ease oncology workloads

Gosta Labs, a Helsinki-based HealthTech company innovating in the oncology sector, has closed a €7.5 million Seed round to scale its AI operating system for complex […]
November 27th, 2025
Korea Tech Desk

Venture Week 2025: Korea Prepares “Four-Pillar Strategy” to Become a Global Venture Powerhouse

Korea’s startup scene is about to pause, reflect, and reimagine its future. In the coming first venture week, the nation’s venture and innovation builders, investors, and […]
November 24th, 2025
Korea Tech Desk

Beyond the Scale-Up “Death Valley”: Korea’s Next Test Is Building Global-First Startups, Not Local Giants

Korea’s startup ecosystem has learned to grow fast — perhaps too fast. The past decade’s state-backed acceleration produced record valuations and bold ambitions, but now the […]
November 22nd, 2025
Korea Tech Today

Samsung Revives Dual-CEO Leadership to Navigate AI Era

Executive reshuffle signals strategic focus on mobile, memory, and next-generation technologies Samsung Electronics has reinstated its dual-CEO management structure as part of its 2026 executive reshuffle, […]
November 21st, 2025
EU-Startups

€99 million Series D fuels Artios’ expansion of precision cancer treatment pipeline

Artios Pharma Limited, a British biopharmaceutical company committed to realising the therapeutic potential of targeting the DNA damage response (DDR) in cancer, today announced the successful […]
November 17th, 2025
EU-Startups

With over €4 billion in AUM, France’s Sofinnova closes Fund XI at €650 million to double down on MedTech magic

Paris-based VC firm Sofinnova Partners has closed its latest flagship fund, Sofinnova Capital XI, at an impressive €650 million – a haul that surpasses its original […]
November 17th, 2025
EU-Startups

Cambridge startup T-Therapeutics secures €27.5 million to improve how the immune system targets disease

T-Therapeutics, a British BioTech company developing next-generation T cell receptor (TCR) therapeutics for cancer and autoimmune disease, today announced the successful expansion of its Series A […]
November 13th, 2025
View more